-transparent.png){kind=logo}
Cerebrospinal fluid (CSF) dopamine-beta-hydroxylase (DBH) activity in 32 male alcoholics was measured using a modification of the radioenzymatic method of Molinoff et al. In most, the CSF was obtained before treatment with disulfiram, while in others it was obtained while they were on the drug (250 or 500 mg). As expected, treatment with this reversible DBH inhibitor had no effect on the activity of the enzyme measured in our in vitro assay. However, low pretreatment DBH activity was found to correlate with adverse reactions to disulfiram. Mean DBH activity of four individuals who went on to become psychotic on disulfiram was 0.13 +/- 0.02 nmole/ml per hr (mean +/- SEM). An additional four individuals who developed dysphoric but nonpsychotic reactions had a mean DBH of 0.23 +/- 0.03. Both these values were significantly lower than the mean DBH activity of the remaining 24 individuals treated with disulfiram who had no adverse side effects, 0.53 +/- 0.06 p less than 0.02 and p less than 0.05, respectively, 2-tailed t-test.
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
January 1976,
Journal of neurochemistry,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
May 1992,
No to hattatsu = Brain and development,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
December 1977,
Journal of neurochemistry,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
July 1964,
Life sciences (1962),
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
February 1994,
Clinical science (London, England : 1979),
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
October 1990,
Neurology,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
January 1981,
Hypertension (Dallas, Tex. : 1979),
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
January 1978,
Alcoholism, clinical and experimental research,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
April 1966,
The Journal of pharmacology and experimental therapeutics,
L F Major, and
P Lerner, and
J C Ballenger, and
G L Brown, and
F K Goodwin, and
W Lovenberg
January 1976,
Neuropsychobiology,
